Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy

Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer

NCT03512847 ·Status: COMPLETED

Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor

NCT04932343 ·Status: UNKNOWN

Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

NCT06907160 ·Status: RECRUITING

Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers

NCT03658460 ·Status: COMPLETED

A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

NCT04312308 ·Status: COMPLETED

irAE Prediction of Anti-PD-1/L1 in Lung Cancer

NCT05288569 ·Status: UNKNOWN

Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer

NCT04918836 ·Status: UNKNOWN

Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer

NCT05260606 ·Status: RECRUITING

Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC

NCT05725915 ·Status: UNKNOWN

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

NCT05198154 ·Status: RECRUITING

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

NCT01482585 ·Status: UNKNOWN

Immune-Marker Platform for Patients With Advanced Lung Cancer

NCT07150598 ·Status: NOT_YET_RECRUITING

Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy

NCT05636605 ·Status: RECRUITING

Detection Cell Free DNA in Lung Cancer Patients

NCT02738593 ·Status: UNKNOWN

Analysis of Plasma Tumor DNA in Lung Cancer Patients

NCT01930474 ·Status: UNKNOWN

Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

NCT04189679 ·Status: COMPLETED

NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy

NCT04636047 ·Status: UNKNOWN

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

NCT05641870 ·Status: UNKNOWN

Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: a Multi - Omics Perspective

NCT06856798 ·Status: NOT_YET_RECRUITING

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients

NCT04203095 ·Status: UNKNOWN

An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore

NCT06232265 ·Status: RECRUITING

Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy

NCT07179445 ·Status: NOT_YET_RECRUITING

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

NCT05023746 ·Status: COMPLETED

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

NCT01517971 ·Status: COMPLETED

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED